Page last updated: 2024-09-03

kelatorphan and oxidopamine

kelatorphan has been researched along with oxidopamine in 2 studies

Compound Research Comparison

Studies
(kelatorphan)
Trials
(kelatorphan)
Recent Studies (post-2010)
(kelatorphan)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
58018,63062,407

Protein Interaction Comparison

ProteinTaxonomykelatorphan (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calenco-Choukroun, G; Daugé, V; Gacel, G; Roques, BP1
Calenco-Choukroun, G; Daugé, V; Féger, J; Roques, BP1

Other Studies

2 other study(ies) available for kelatorphan and oxidopamine

ArticleYear
Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    European journal of pharmacology, 1991, Dec-17, Volume: 209, Issue:3

    Topics: Amino Acid Sequence; Analgesics; Animals; Behavior, Animal; Dipeptides; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Limbic System; Male; Molecular Sequence Data; Motor Activity; Neurons; Nucleus Accumbens; Oligopeptides; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Tegmentum Mesencephali

1991
Behavioral effects of endogenous or exogenous (mu, delta) opioid peptides: relation with DA mesolimbic pathways.
    Progress in clinical and biological research, 1990, Volume: 328

    Topics: Animals; Dipeptides; Dopamine; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hydroxydopamines; Limbic System; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu

1990